Our study adds to the growing literature of reported nonfunctional PNETs in hopes to encourage the creation of consensus guidelines and utilization of mTOR inhibitor therapy for this rare clinical feature of TSC. The gene discussed is MTOR; the disease is tuberous sclerosis.